Skip to content
Nephrology

AKI management & renal emergencies

Fix volume, stop NSAIDs/ACE/ARB if prerenal/AKI, avoid hyperglycemia and unnecessary contrast. Large-volume resuscitation: LR > NS (SMART/SALT-ED).

Anishaa Sivakumar6 min6 questions6 trials

Management

  1. Optimize hemodynamics, avoid nephrotoxins. Correct volume: IVF and hold diuretics if hypovolemic; diurese if hypervolemic. Stop NSAIDs / ACE inhibitors / ARBs. Avoid hyperglycemia and contrast. No evidence of benefit for empiric diuretics in oliguria (). If large-volume resuscitation or critically ill, generally LR > NS (; ).
  2. Renally dose meds (Lexicomp by GFR). GFR calculations assume steady state: if creatinine is rising, assume clearance is lower than the reported eGFR; if anuric, assume GFR is 0. Run the MAR with pharmacy. Consider cystatin C if eGFR looks wrong ( CKD Guidelines).
  3. Manage complications — hyperK, hyperphos, metabolic acidosis, uremic bleeding.
  4. Dialyze when AEIOU is met.
ComplicationMove
HyperkalemiaECG, telemetry until improved. Stabilize with calcium gluconate, shift with insulin/dextrose and albuterol, then remove K with sodium zirconium cyclosilicate (Lokelma), bowel regimen, furosemide. Low-K diet.
HyperphosphatemiaSevelamer if P >5.5 mg/dL vs calcium acetate depending on calcium. Avoid IV calcium if Ca × Phos product >70 (precipitation). Low-phos diet.
Metabolic acidosisSodium bicarbonate PO/IV (see Acid-Base).
Uremic platelets / bleedingDDAVP 0.3 mcg/kg IV; onset 1 h, lasts 4–8 h.
AEIOU — indications for dialysis
  1. A

    Acidosis

    Especially pH <7.0, refractory to bicarbonate.

  2. E

    Electrolytes

    Refractory hyperkalemia.

  3. I

    Intoxication

    Lithium, ethylene glycol, metformin, salicylates, theophylline.

  4. O

    Overload

    Refractory volume overload.

  5. U

    Uremia

    Encephalopathy, neuropathy, pericarditis — not a BUN number.

Uremic emergencies, not a lab cutoff. Page renal when the temporizing moves are failing.

When to page the renal fellow overnight

EmergencyThresholdTemporize while they walk over
AcidosispH <7.1, or <7.2 with severe AKI, without a rapidly reversible cause (i.e. not DKA)Bicarb pushes and isotonic bicarb drip. Intubate and hyperventilate if they cannot blow off CO2.
HyperkalemiaECG changes / arrhythmia, or K >6.5 (>5.5 if rising rapidly from rhabdo / GI bleed)Calcium gluconate, diuretics, insulin/D50, albuterol. iHD clears K faster than CVVH — prefer iHD in stable patients who can tolerate it.
HyponatremiaNa <120, symptomatic (AMS with low GCS, seizures), or needing 3% saline ± DDAVP clampSee Sodium disorders. Do not free-water-restrict a seizing patient.
Anuria with ADHFNo urine, wet, and the heart is the reasonFoley. Monitor UOP / MvO2 / labs (LFTs, Cr, lactate, CI). Raising cardiac output (diuresis or HD, ± inotropes) raises GFR.
IngestionsLithium; ethylene glycol / methanol (osmolar gap → anion gap); metformin with end-organ damage (renal failure, vision loss)AEIOU. Call toxicology with renal.
RPGNActive sediment, rising Cr over days–weeks, systemic vasculitis cluesUrgent consult for pulse steroids ± plasmapheresis. See Glomerular disease.
Scleroderma renal crisisAbrupt severe HTN then oliguric renal failure in diffuse sclerodermaACE inhibitor (captopril) at the maximum tolerated dose, starting 6.25 or 12.5 mg, titrating q4h. Avoid steroids.

Cause-specific treatment

  • AIN: stop the offender. Consider prednisone 40–60 mg daily for 1–2 weeks if biopsy-confirmed or high pretest probability — evidence is not great ().
  • HRS: see Hepatorenal Syndrome.
  • Post-renal: Foley, α-blockers; 5α-reductase inhibitor (effect is not immediate); urology / IR if a perc nephrostomy is needed.

Cardiorenal syndrome (type 1)

Five phenotypes link heart and kidney; type 1 is HF causing AKI (; ). Decreased renal perfusion from ↑ venous congestion ± ↓CO yields a low trans-renal perfusion pressure. This is more “under-draining” (congestion) than “under-filling” (perfusion).

  • Treat by relieving renal venous congestion. Trend Cr against total-body balance and daily weights; expect a lag.
  • Loop diuretics first-line ± a thiazide (metolazone / chlorothiazide). See Advanced diuresis.
  • No benefit of low-dose dopamine or nesiritide to improve forward flow (, ).
  • Ultrafiltration: similar weight loss and CHF symptoms, worse renal function vs stepped loop/thiazide therapy (, ).

Contrast-associated AKI

Definition: ↑Cr ≥0.5 or 25% within 48–72 h of contrast; CA-AKI means the AKI is causally related to the contrast (; ; ACR 2025;35). Starts 24–48 h, peaks 3–5 days, resolves ~10 days; usually non-oliguric. Recent data: risk is lower than older estimates and hard to separate from background Cr noise (Ann Em Med 2017;69:577). Mechanism: vasospasm vs osmotic tubular injury.

  • Risk factors: higher contrast load, hyperosmolar contrast, intra-arterial injection (cardiac cath), DM, proteinuria, concomitant AKI.
  • Prophylaxis for high-risk patients (GFR <30, or 30–45 plus DM) receiving arterial/IV contrast: consider IV NS per protocol. If treating volume overload, hold diuretics the day of contrast with no extra IVF.
  • No added benefit of IV bicarb or NAC (, ), or of pre/post/intra HD in anuric patients ().
  • Balance CA-AKI risk against the harm of delaying a diagnosis that would change treatment.

Crystals, casts, muscle

  • Crystalline nephropathy: stop the drug. Fomepizole / HD for ethylene glycol. Rasburicase / HD for TLS. IVF and diuresis for acyclovir (goal UOP >150 mL/h).
  • Myeloma kidney (cast nephropathy): total protein/Cr, SPEP/UPEP/SFLC; kidney biopsy if the diagnosis is unclear. IV hydration to UOP >3 L/day to limit precipitation (volume overload can be diuresed); chemotherapy to cut light-chain production. Plasmapheresis has unclear benefit given rebound production.
  • Rhabdomyolysis: AKI is unlikely unless CK >20,000. Aggressive NS for UOP >250 mL/h. Consider isotonic sodium bicarb if marked acidosis () and no hypocalcemia — no convincing evidence HCO3 is superior to NS. Watch hyperK and hypoCa. Continue aggressive IVF until CK <5,000; once volume-replete, keep IVF going with close monitoring and diuresis as needed.